rexmyelocel-t
Cell therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Apr 5, 2017 (NCT03174522)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Stem CellTissue restoration
Stem Cell tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rexmyelocel-t
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03111238 | Phase 3 | Apr 5, 2017 | Ixaka |
| NCT03174522 | Phase 3 | Apr 5, 2017 | Ixaka |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ixaka | For profit | 2 | 2 | 1 | 2017 |
1 organizations
Page 1 / 1